Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications

Mol Cancer. 2018 Jan 5;17(1):2. doi: 10.1186/s12943-017-0755-z.

Abstract

Pancreatic cancer is one of the most lethal cancers worldwide due to its insidious symptoms, early metastasis, and chemoresistance. Hence, the underlying mechanisms contributing to pancreatic cancer progression require further exploration. Based on accumulating evidence, extracellular vesicles, including exosomes and microvesicles, play a crucial role in pancreatic cancer progression and chemoresistance. Furthermore, they also possess the potential to be promising biomarkers, therapy targets and tools for treating pancreatic cancer. Therefore, in-depth studies on the role of extracellular vesicles in pancreatic cancer are meaningful. In this review, we focus on the regulatory effects of extracellular vesicles on pancreatic cancer progression, metastasis, cancer-related immunity and chemoresistance, particularly their potential roles as biomarkers and therapeutic targets.

Keywords: Chemoresistance; Clinical applications; Extracellular vesicles; Pancreatic cancer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers
  • Cell Movement / genetics
  • Cell Proliferation
  • Cell-Derived Microparticles
  • Disease Progression
  • Drug Resistance, Neoplasm*
  • Extracellular Matrix / metabolism
  • Extracellular Vesicles / metabolism*
  • Humans
  • Immune Tolerance
  • Immunologic Surveillance
  • Neoplasm Metastasis
  • Pancreatic Neoplasms / diagnosis
  • Pancreatic Neoplasms / drug therapy
  • Pancreatic Neoplasms / immunology
  • Pancreatic Neoplasms / metabolism*
  • Prognosis
  • Tumor Microenvironment

Substances

  • Biomarkers